North Star Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
25,588
+24
+0.1% +$1.4K 0.09% 206
2025
Q4
$1.38M Buy
25,564
+150
+0.6% +$7.22K 0.09% 201
2025
Q3
$1.15M Hold
25,414
0.07% 213
2025
Q2
$1.18M Sell
25,414
-662
-3% -$32.5K 0.08% 202
2025
Q1
$1.59M Sell
26,076
-777
-3% -$45.3K 0.12% 178
2024
Q4
$1.52M Buy
26,853
+491
+2% +$27.4K 0.11% 175
2024
Q3
$1.36M Sell
26,362
-1,321
-5% -$62K 0.09% 196
2024
Q2
$1.15M Sell
27,683
-871
-3% -$39K 0.08% 213
2024
Q1
$1.55M Sell
28,554
-108
-0.4% -$5.5K 0.11% 184
2023
Q4
$1.47M Sell
28,662
-45,601
-61% -$2.39M 0.11% 184
2023
Q3
$4.31M Sell
74,263
-974
-1% -$59.7K 0.36% 72
2023
Q2
$4.81M Sell
75,237
-1,995
-3% -$134K 0.39% 60
2023
Q1
$5.35M Buy
77,232
+1,388
+2% +$97.9K 0.44% 56
2022
Q4
$5.46M Buy
75,844
+64
+0.1% +$4.83K 0.48% 49
2022
Q3
$5.39M Buy
75,780
+4
+0% +$290 0.53% 46
2022
Q2
$5.83M Sell
75,776
-6,995
-8% -$533K 0.53% 45
2022
Q1
$6.04M Sell
82,771
-393
-0.5% -$26.4K 0.47% 54
2021
Q4
$5.18M Sell
83,164
-297
-0.4% -$17.4K 0.36% 65
2021
Q3
$4.94M Sell
83,461
-1,246
-1% -$82.1K 0.4% 64
2021
Q2
$5.66M Sell
84,707
-101
-0.1% -$6.59K 0.45% 56
2021
Q1
$5.35M Sell
84,808
-240
-0.3% -$14.9K 0.5% 52
2020
Q4
$5.28M Sell
85,048
-5,465
-6% -$336K 0.55% 47
2020
Q3
$5.46M Buy
90,513
+1,499
+2% +$90.2K 0.64% 38
2020
Q2
$5.23M Sell
89,014
-16,985
-16% -$1.02M 0.68% 34
2020
Q1
$5.91M Sell
105,999
-750
-0.7% -$45.8K 0.87% 24
2019
Q4
$6.85M Buy
106,749
+2,400
+2% +$137K 0.71% 31
2019
Q3
$5.29M Buy
104,349
+24,736
+31% +$1.16M 0.59% 44
2019
Q2
$3.61M Buy
79,613
+41,105
+107% +$1.91M 0.42% 65
2019
Q1
$1.84M Buy
38,508
+5
+0% +$249 0.21% 132
2018
Q4
$2M Buy
38,503
+4
+0% +$215 0.26% 110
2018
Q3
$2.39M Buy
38,499
+501
+1% +$29.7K 0.27% 102
2018
Q2
$2.1M Buy
37,998
+1
+0% +$54 0.24% 111
2018
Q1
$2.4M Sell
37,997
-950
-2% -$61.1K 0.29% 93
2017
Q4
$2.39M Buy
38,947
+5,763
+17% +$360K 0.29% 101
2017
Q3
$2.12M Buy
33,184
+601
+2% +$35.1K 0.27% 107
2017
Q2
$1.82M Buy
32,583
+1,260
+4% +$68.6K 0.24% 116
2017
Q1
$1.7M Sell
31,323
-176
-0.6% -$9.65K 0.23% 117
2016
Q4
$1.84M Buy
31,499
+9,125
+41% +$499K 0.28% 105
2016
Q3
$1.21M Sell
22,374
-730
-3% -$46.9K 0.21% 127
2016
Q2
$1.7M Sell
23,104
-411
-2% -$29K 0.31% 98
2016
Q1
$1.5M Sell
23,515
-200
-0.8% -$12.6K 0.29% 98
2015
Q4
$1.63M Hold
23,715
0.32% 92
2015
Q3
$1.4M Sell
23,715
-200
-0.8% -$12.7K 0.29% 97
2015
Q2
$1.59M Sell
23,915
-50
-0.2% -$3.29K 0.29% 108
2015
Q1
$1.55M Hold
23,965
0.29% 111
2014
Q4
$1.42M Buy
23,965
+9,600
+67% +$541K 0.27% 113
2014
Q3
$735K Hold
14,365
0.15% 163
2014
Q2
$697K Sell
14,365
-28,112
-66% -$1.39M 0.14% 169
2014
Q1
$2.21M Buy
42,477
+1,500
+4% +$79.8K 0.46% 56
2013
Q4
$2.18M Sell
40,977
-2,900
-7% -$148K 0.47% 58
2013
Q3
$2.03M Hold
43,877
0.54% 55
2013
Q2
$1.96M Buy
+43,877
New +$1.9M 0.51% 54

Other funds holding BMY

North Star Investment Management's BMY Position: Q1 2026 in Review

North Star Investment Management increased its Bristol-Myers Squibb (BMY) stake by 0.09% in Q1 2026, buying an estimated $1.4K and bringing the position to 25,588 shares worth $1.55M. The position accounts for 0.09% of the portfolio, ranked #206.

North Star Investment Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.85M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • North Star Investment Management held 25,588 shares of Bristol-Myers Squibb worth $1.55M as of Q1 2026.
  • North Star Investment Management bought 24 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.4K.
  • Bristol-Myers Squibb made up 0.09% of North Star Investment Management's portfolio in Q1 2026, its #206 holding.
  • North Star Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • North Star Investment Management's Bristol-Myers Squibb position peaked at $6.85M in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.